AEON Biopharma (AEON)
NYSE MKT:AEON
US Market
Holding AEON?
Track your performance easily

AEON Biopharma (AEON) Financial Statements

92 Followers

AEON Biopharma Financial Overview

AEON Biopharma's market cap is currently ―. The company's EPS TTM is $0.523; its P/E ratio is 1.43; AEON Biopharma is scheduled to report earnings on August 12, 2024, and the estimated EPS forecast is $-0.19. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Sep 23Dec 22Sep 22Jun 22
Income Statement-
Total Revenue----$ 0.00
Gross Profit-----
EBIT$ -31.25M$ 43.88M$ 4.33M$ -10.44M$ -427.20K
EBITDA$ -31.22M$ 43.88M$ 4.33M$ -10.40M$ -427.20K
Net Income Common Stockholders$ -31.25M$ 22.63M$ -46.76M$ -10.44M$ 1.87M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 1.56M$ 16.20M$ 67.91K$ 27.76K$ 7.76K
Total Assets$ 3.03M$ 17.62M$ 279.49M$ 277.32M$ 276.51M
Total Debt$ 5.09M$ 52.00K$ 0.00$ 0.00$ 0.00
Net Debt$ 3.53M$ -16.15M$ -67.91K$ -27.76K$ -7.76K
Total Liabilities$ 201.41M$ 139.36M$ 10.44M$ 11.97M$ 12.80M
Stockholders Equity$ -186.36M$ -121.74M$ -9.44M$ -11.55M$ 263.71M
Cash Flow-
Free Cash Flow$ -8.60M$ -15.06M$ -170.28K$ -26.86M$ -158.49K
Operating Cash Flow$ -8.60M$ -15.06M$ -170.28K$ -26.56M$ -158.49K
Investing Cash Flow--$ 60.42K$ -377.50K$ 0.00
Financing Cash Flow$ 5.00M-$ 150.00K$ 44.50M$ 0.00
Currency in USD

AEON Biopharma Earnings and Revenue History

AEON Biopharma Debt to Assets

AEON Biopharma Cash Flow

AEON Biopharma Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis